UBS Group AG - ANGION BIOMEDICA CORP ownership

ANGION BIOMEDICA CORP's ticker is ANGN and the CUSIP is 03476J107. A total of 54 filers reported holding ANGION BIOMEDICA CORP in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ANGION BIOMEDICA CORP
ValueSharesWeighting
Q1 2023$8,406
+4.6%
14,492
+46.1%
0.00%
Q4 2022$8,035
+14.8%
9,919
+37.0%
0.00%
Q3 2022$7,000
-41.7%
7,240
-34.0%
0.00%
Q2 2022$12,000
+1100.0%
10,969
+2253.9%
0.00%
Q1 2022$1,000
-96.0%
466
-94.5%
0.00%
Q4 2021$25,000
+733.3%
8,537
+3834.1%
0.00%
Q2 2021$3,000
-89.7%
217
-86.7%
0.00%
Q1 2021$29,0001,6300.00%
Other shareholders
ANGION BIOMEDICA CORP shareholders Q4 2021
NameSharesValueWeighting ↓
CM Management, LLC 600,000$552,0000.62%
Nantahala Capital Management 1,066,012$981,0000.06%
BVF INC/IL 1,071,297$986,0000.04%
Birchview Capital, LP 54,392$50,0000.04%
Park West Asset Management LLC 370,724$341,0000.02%
Cannell Capital 40,181$37,0000.01%
Patriot Financial Group Insurance Agency, LLC 36,500$34,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 175,000$161,0000.00%
Valeo Financial Advisors, LLC 63,659$59,0000.00%
Ergoteles LLC 78,857$73,0000.00%
View complete list of ANGION BIOMEDICA CORP shareholders